By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and enhance user experience. Learn more
Josie has extensive experience in market access for rare diseases. She led the establishment of the Highly Specialised Technologies programme at NICE in the UK, including the introduction of a process for Managed Access Agreements to facilitate access to treatments for very rare diseases. She is also currently leading Duchenne UK’s Project HERCULES and fostering international multi-stakeholder collaboration to develop evidence and support tools for HTA for new treatments for Duchenne Muscular Dystrophy.
© Hanover Communications 2024, an AVENIR GLOBAL company. All rights reserved.
